Scientific Sessions 2025  /  Transformative Advances in Genome Engineering for Precision Therapy  /  Treating cardiovascular disease with Base and Prime Editing
Logo

American Heart Association

  90
  0

Final ID:

Treating cardiovascular disease with Base and Prime Editing

  • Seidman, Christine  ( HARVARD MEDICAL SCHOOL , Boston , Massachusetts , United States )
  • Steinmetz, Lars  ( Stanford University , LA , California , United States )
  • Olson, Eric  ( UNIV TEXAS SOUTHWESTERN MED CTR , Dallas , Texas , United States )
    • Author Disclosures:
    Christine Seidman: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Merck, Board of Directors:Active (exists now) ; Advisor:Tenaya:Active (exists now) ; Advisor:Maze:Past (completed) | Lars Steinmetz: DO have relevant financial relationships ; Consultant:Sophia Genetics:Active (exists now) ; Consultant:Levitas Bio:Active (exists now) | Eric Olson: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Transformative Advances in Genome Engineering for Precision Therapy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Developing single course in vivo gene editing therapies for hyperlipidemia

Kathiresan Sekar, Musunuru Kiran, Ishikawa Kiyotake

RNA editing: a tractable future therapeutic?

Weldy Chad, Gan Li-ming, Stafforst Thorsten

More abstracts from these authors:
So How Do We Determine the Right Strategy for the Right Patient?

Watkins Hugh, Seidman Christine

Gene Therapy: The Next Frontier or Fool's Gold?

Seidman Christine, Watkins Hugh

You have to be authorized to contact abstract author. Please, Login
Not Available